Augmentin and Urocit-k drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin (amoxicillin; clavulanate potassium) and Urocit-k (potassium citrate). Common drug interactions include adrenal insufficiency among females and haemorrhage intracranial among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin and Urocit-k. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin?

Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.

What is Urocit-k?

Urocit-k has active ingredients of potassium citrate. It is often used in kidney stones. eHealthMe is studying from 708 Urocit-k users. Check the latest studies of Urocit-k.

On Jul, 26, 2026

11 people who take Augmentin and Urocit-k together, and have interactions are studied.

Augmentin and Urocit-k drug interactions.

What are the common drug interactions of Augmentin and Urocit-K, by gender? *:

female:

Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Metastases to bone marrow (cancer spreads to bone marrow)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Phlebitis (inflammation of the walls of a vein)
Pulmonary mass
Pyrexia (fever)
Speech disorder
Anaemia of malignant disease
Arteriosclerosis (thickening and hardening of arteries)

male:

Haemorrhage intracranial (bleeding within the skull)
Thrombocytopenia (decrease of platelets in blood)
Lymphocyte count decreased
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Platelet count decreased
Pruritus (severe itching of the skin)
White blood cell count decreased

What are the common drug interactions of Augmentin and Urocit-K, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Diarrhoea
Drug intolerance (drug sensitivity)
Duodenal polyp (duodenal epithelial tumours)
Dysplasia (enlargement of an organ or tissue)
Dystrophic calcification (calcification occurring in degenerated or necrotic tissue)
Erythema (redness of the skin)
Exposed bone in jaw
Febrile neutropenia (fever with reduced white blood cells)

50-59:

Arteriosclerosis (thickening and hardening of arteries)
Arthralgia (joint pain)
Asthenia (weakness)
Back pain
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Bullous lung disease
Cardiomegaly (increased size of heart than normal)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)

60+:

Haemorrhage intracranial (bleeding within the skull)
Thrombocytopenia (decrease of platelets in blood)
Lymphocyte count decreased
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Platelet count decreased
White blood cell count decreased

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 4 people, 36.36%
Bone Loss: 4 people, 36.36%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 27.27%
Lymphoma (cancer that begins in immune system cells): 3 people, 27.27%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 27.27%
Quit Smoking: 1 person, 9.09%
Prostatitis (inflammation of the prostate gland): 1 person, 9.09%
Metastases To Bone (cancer spreads to bone): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin and Urocit-k?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously